Evidence map›Paper›PMID 35945544›Full record

ArticleGenome biology2022

A benchmark study of deep learning-based multi-omics data fusion methods for cancer.

Dongjin Leng, Linyi Zheng, Yuqi Wen, Yunhao Zhang, Lianlian Wu, Jing Wang, Meihong Wang, Zhongnan Zhang, Song He, Xiaochen Bo

Abstract read
In one paragraph

Article in Genome biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. SurvGRN: a multi-feature fusion framework for bladder cancer survival prediction.International journal of surgery (London, England) · 2026
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. ASTRO: Automated Spatial-Transcriptome whole RNA Output.Bioinformatics (Oxford, England) · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dongjin Leng *Institute of Health Service and Transfusion Medicine, Beijing, People's Republic of China.
Linyi Zheng *School of Informatics, Xiamen University, Xiamen, People's Republic of China.
Yuqi Wen *Institute of Health Service and Transfusion Medicine, Beijing, People's Republic of China.
Yunhao ZhangSchool of Informatics, Xiamen University, Xiamen, People's Republic of China.
Lianlian WuAcademy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, People's Republic of China.
Jing WangSchool of Medicine, Tsinghua University, Beijing, People's Republic of China.
Meihong WangSchool of Informatics, Xiamen University, Xiamen, People's Republic of China.
Zhongnan ZhangSchool of Informatics, Xiamen University, Xiamen, People's Republic of China. zhongnan_zhang@xmu.edu.cn.
Song HeInstitute of Health Service and Transfusion Medicine, Beijing, People's Republic of China. hes1224@163.com.
Xiaochen BoInstitute of Health Service and Transfusion Medicine, Beijing, People's Republic of China. boxc@bmi.ac.cn.ORCID 0000-0003-1911-7922

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA fused method using a combination of multi-omics data enables a comprehensive study of complex biological processes and highlights the interrelationship of relevant biomolecules and their functions. Driven by high-throughput sequencing technologies, several promising deep learning methods have been proposed for fusing multi-omics data generated from a large number of samples.

resultsIn this study, 16 representative deep learning methods are comprehensively evaluated on simulated, single-cell, and cancer multi-omics datasets. For each of the datasets, two tasks are designed: classification and clustering. The classification performance is evaluated by using three benchmarking metrics including accuracy, F1 macro, and F1 weighted. Meanwhile, the clustering performance is evaluated by using four benchmarking metrics including the Jaccard index (JI), C-index, silhouette score, and Davies Bouldin score. For the cancer multi-omics datasets, the methods' strength in capturing the association of multi-omics dimensionality reduction results with survival and clinical annotations is further evaluated. The benchmarking results indicate that moGAT achieves the best classification performance. Meanwhile, efmmdVAE, efVAE, and lfmmdVAE show the most promising performance across all complementary contexts in clustering tasks.

conclusionsOur benchmarking results not only provide a reference for biomedical researchers to choose appropriate deep learning-based multi-omics data fusion methods, but also suggest the future directions for the development of more effective multi-omics data fusion methods. The deep learning frameworks are available at https://github.com/zhenglinyi/DL-mo .

Indexed as

Deep LearningNeoplasmsAlgorithmsBenchmarkingCluster AnalysisHumans

Identifiers

PMID35945544
PMCPMC9361561

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.